← Back to Home

4basecare.com Scam Check: 100/100 Trust | ScamMinder

Website: 4basecare.com

Screenshot of 4basecare.com

Safety Score

100/100
✓ Safe Website

This website appears legitimate based on AI analysis.

AI Analysis Results

Category: Health
About this website:

4basecare.com appears to be a legitimate website for a precision oncology company. The site promotes its services and products, including a cancer gene panel and a digital health platform. It also mentions key individuals associated with the company, such as Ms. Revathi, Mr. Satheesh Kumar, and Dr. Natasha Khurshid. The website emphasizes the role of comprehensive genomic profiling (CGP) in identifying new treatment options for recurrent cancers and in determining EGFR mutation status in lung cancer when liquid biopsy fails. Additionally, it highlights the company's partnership with Illumina Accelerator, a well-known biotech accelerator. The site's use of SSL encryption (Let's Encrypt) and its long domain age (7 years and 6 months) are positive indicators of legitimacy. However, it's important to conduct further research and due diligence, especially if considering any business or medical engagement with the company. This can include verifying the credentials of the individuals mentioned, checking for independent reviews or news articles about the company, and ensuring that any medical claims are supported by scientific evidence."

Risk Assessment: safe
📊 Analysis Reasons:
  • Long domain age (7 years and 6 months) is a positive indicator of legitimacy. Use of SSL encryption (Let's Encrypt) provides a secure connection for website visitors. The website promotes precision oncology services and products, including a cancer gene panel and a digital health platform. It mentions key individuals associated with the company, such as Ms. Revathi, Mr. Satheesh Kumar, and Dr. Natasha Khurshid. Emphasizes the role of comprehensive genomic profiling (CGP) in identifying new treatment options for recurrent cancers. Highlights the importance of CGP in determining EGFR mutation status in lung cancer when liquid biopsy fails. Mentions a partnership with Illumina Accelerator, a well-known biotech accelerator.